ezlopitant has been researched along with ketorolac in 1 studies
Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (ketorolac) | Trials (ketorolac) | Recent Studies (post-2010) (ketorolac) |
---|---|---|---|---|---|
22 | 2 | 1 | 1,778 | 668 | 725 |
Protein | Taxonomy | ezlopitant (IC50) | ketorolac (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.013 | |
Caspase-1 | Homo sapiens (human) | 1.3025 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.282 | |
Caspase-3 | Homo sapiens (human) | 1.3025 | |
Caspase-4 | Homo sapiens (human) | 1.3025 | |
Caspase-5 | Homo sapiens (human) | 1.3025 | |
Caspase-9 | Homo sapiens (human) | 1.3025 | |
Cell division control protein 42 homolog | Homo sapiens (human) | 2 | |
Ras-related C3 botulinum toxin substrate 1 | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
1 other study(ies) available for ezlopitant and ketorolac
Article | Year |
---|---|
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |